About This Publication:

  • Print This Page
  • Text a Friend
  • Subscribe to an RSS Feed

Sample Content 

LOGIN


Sign up to stay informed--receive email notifications for this journal

Journal of Interferon
& Cytokine Research

Editors-in-Chief: Ganes C. Sen and Thomas A. Hamilton

ISSN: 1079-9907 • Published Monthly • Online ISSN: 1557-7465

Current Volume: 34

Latest Impact Factor* is 3.297

*2012 Journal Citation Reports® published by Thomson Reuters, 2013

Open Access Options for this Peer-Reviewed Journal


Choose Liebert Open Access Option!

Ensure maximum visibility, discoverability, and impact for your article with our Liebert Open Access (OA) Option.

Your investment guarantees:

  • Immediate, unrestricted global access in 170 countries
  • Maximum visibility for increased readers, citations, and downloads
  • Targeted email announcement highlighting your article to thousands of thought-leaders in your field
  • Rapid, rigorous peer-review and editorial attention
  • Fast Track online-ahead-of-print publication
  • Immediate upload to PubMed Central and other internationally recognized repositories*
  • Recognition on online Table of Contents with exclusive OA icon
  • Compliance with OA funding mandates with no embargo period
  • Savings on future OA article publication
  • Complimentary membership in AuthorCite®, the author services platform exclusively licensed by Mary Ann Liebert, Inc. that delivers the tools you need to maximize your professional impact.

These valuable benefits are included with a one-time article processing charge (APC). APC charge varies based on journal, membership, and subsequent submissions.

Contact openaccess@liebertpub.com for questions on article Open Access options. 

 *Please note that PubMedCentral, not the Publisher, has sole control over when the paper is made live on PMC.

 

Is your Institution a member of the Liebert Author Advocacy Program?

The Liebert Author Advocacy Program (LAAP) provides valuable membership benefits for OA publication to institutional and funding organizations, and supports global funding mandates.  Authors who are affiliated with LAAP member institutions receive all the valuable benefits of Liebert OA article publication, and more.

For details, and to recommend institutional membership visit: www.authoradvocacy.com or contact laap@liebertpub.com 

 

 

 

The views, opinions, findings, conclusions and recommendations set forth in any Journal article are solely those of the authors of those articles and do not necessarily reflect the views, policy or position of the Journal, its Publisher, its editorial staff or any affiliated Societies and should not be attributed to any of them.

Recommended Publications

You may be interested in the following publications:

    Viral Immunology

    Viral Immunology

    The only journal reporting on all aspects of the rapidly growing field of viral immunology, with comprehensive coverage of immune responses to viral infections from basic mechanisms to clinical applications.

    Monoclonal Antibodies
    in Immunodiagnosis
    and Immunotherapy

    Monoclonal Antibodies
    in Immunodiagnosis
    and Immunotherapy

    formerly Hybridoma

    The essential journal for scientists and clinicians in the fields of molecular immunology and immunopathology, and for all those applying molecular immunological methods for experimental and therapeutic purposes.

    AIDS Research and Human Retroviruses

    AIDS Research and Human Retroviruses

    The leading journal in the field for over 25 years, providing the latest developments and research advances in HIV/AIDS and other retroviruses leading to improvements in translational medicine for optimal treatment outcomes.

    Cancer Biotherapy and Radiopharmaceuticals

    Cancer Biotherapy and Radiopharmaceuticals

    The established journal with over 25 years of peer-reviewed papers on new and innovative investigations of methods to improve cancer therapy. The Journal focuses on advancements in radioimmunotherapy and radiopharmaceuticals.

Browse All Publications »